COPD News

Healio Pulmonology has you covered. The Editors have compiled a list of the most-popular articles posted on Healio Pulmonology in August.

New data from the ETHOS trial showed that triple-combination therapy with budesonide, glycopyrronium and formoterol at two different budesonide doses reduced exacerbations in patients with moderate to very severe COPD, according to a manufacturer press release.

Among patients with COPD, targeted lung denervation in addition to optimal pharmacotherapy, as compared with pharmacotherapy alone, was associated with fewer respiratory events including exacerbations, according to data from the AIRFLOW-2 study.

Limited health literacy and fluid cognitive ability deficits are associated with lower adherence to self-management behaviors in patients with COPD, an observational cohort study suggests.

Long-term exposure to common air pollutants is associated with significant progression of emphysema, according to an 18-year study published in JAMA.

More than one-third of patients with COPD worldwide may have osteoporosis, according to a systematic review and meta-analysis published in CHEST.

New data from the COLIBRI-COPD French cohort demonstrate a significant shift in physician prescribing patterns for COPD therapy during the past 6 years.

Healio Pulmonology has you covered. The Editors have compiled a list of the most-popular articles posted on Healio Pulmonology in July.

Pulmonary rehabilitation significantly improves symptoms of depression and anxiety in patients with COPD, according to a study.

The use of point-of-care testing for C-reactive protein to guide treatment lessened the use of antibiotics for COPD exacerbations without worsening clinical outcomes, according to a study published in The New England Journal of Medicine.